Atelectasis
0
Pipeline Programs
3
Companies
3
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
3 companies ranked by most advanced pipeline stage
Baxter InternationalDEERFIELD, IL
2 programsMetaNeb® SystemN/A1 trial
The MetaNeb® SystemN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
AmbuBronchoscopic procedure
Baxter InternationalThe MetaNeb® System
Baxter InternationalMetaNeb® System
Clinical Trials (3)
Total enrollment: 439 patients across 3 trials
Evaluation of BAL Procedure With Ambu aScope 3 Large in Patients in an ICU Setting
Start: Sep 2017Est. completion: Jul 201812 patients
N/ATerminated
MetaNeb® Chest X-ray Study
Start: Sep 2016Est. completion: Aug 20178 patients
N/ACompleted
Evaluation of The MetaNeb® System to Reduce Postoperative Pulmonary Complications
Start: Mar 2016Est. completion: Aug 2017419 patients
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
3 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.